Cognition Therapeutics Inc

Ownership Transactions Reported by 17 Insiders

Symbol
CGTX on Nasdaq
Industry
Biological Products, (No Diagnostic Substances)
Location
2403 Sidney Street, Suite 261, Pittsburgh, PA

Insiders trading volume in the past year

Cognition Therapeutics Inc executives and other stock owners filed with the SEC include:

Name Relationship Holdings Value Past Year Net Change Change % Report Date
Aaron G.L. Fletcher Director, 10%+ Owner $14.9M Sep 19, 2025
Ogden CAP Associates, LLC 10%+ Owner $2.32M Oct 13, 2021
Leslie W. Kreis Director, 10%+ Owner $2M Jun 18, 2025
BIOS Memory SPV I, LP 10%+ Owner $1.5M Oct 13, 2021
Lisa Ricciardi CEO & President, Director $642K +$30K +4.9% Jul 29, 2025
Bios Clinical Opportunity Fund, LP Director, 10%+ Owner $525K Nov 8, 2023
Mark H. Breedlove Director $433K Oct 13, 2021
Anthony Caggiano Chief Medical Officer $310K Jul 29, 2025
John Brendan Doyle Chief Financial Officer $285K Jul 29, 2025
Peggy Wallace Director $28.5K Jun 18, 2025
Ellen B. Richstone Director $19.3K Jun 18, 2025
Jack A. Khattar Director $16K Jun 18, 2025
Brett P. Monia Director $16K Jun 18, 2025
James O'Brien Chief Financial Officer $5.25K Mar 23, 2022
Golden Seeds Cognition Therapeutics LLC 10%+ Owner Sep 27, 2022
Andrew J. Einhorn Interim CFO Aug 12, 2022
BP Directors, LP Affiliate of director Jan 31, 2022

Recent Insider Transactions by Companies or Individuals for Cognition Therapeutics Inc

Insider Symbol Class Transaction % Value $ * Price $ Shares Shares Owned Date Ownership
* An asterisk sign (*) next to the price indicates that the price is likely invalid.